A GEPIA survival analysis conducted with data from TCGA and GTEx indicated the quartile of patients with the highest tumor chemerin expression had better overall survival than those in the lowest quartile (Figure 7b), providing preliminary support that the differential chemerin expression could be functionally important in pRCC [106]. This evidence concerns the gene RARRES2 and neoplasm.